$120.80
-22.86 (-15.91%)
Analyst Consensus
Buy
17
Analysts
High
Coverage
Price Target
Analyst Price Target
-72.2% upside
Low Target
$28.45
Average Target
$33.59
High Target
$56.21
Current Price
$120.80
Current
$120.80
$120.80
Target
$33.59
$33.59
$28.45
$33.59 avg
$56.21
Scenario Analysis
Bear Case
$28.45
-76.4%
Low target
Base Case
$33.59
-72.2%
Avg target
Bull Case
$56.21
+-53.5%
High target
Risk/Reward
0.7x
Unfavorable
Price in Context
52-Week High
$166.48
-27.4% from high
52-Week Low
$41.50
+191.1% from low
50-Day SMA
$115.55
+4.5% vs SMA
200-Day SMA
$78.67
+53.6% vs SMA
RSI (14)
53.9
Neutral
Target vs 52W High
$33.59
-79.8% vs high
Next Earnings Report
Nov 10, 2026
3d
until earnings
EPS Est: $-2.65
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -10.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +116.4% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.2% |
| MRNA | Hold | 31 | 35% | $149.45 | -38.1% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -60.7% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -35.8% |